Plunkett Research Online: Vernalis plc

VERNALIS PLC (VNLPY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vernalis plc discovers, researches and develops new compounds for central nervous system (CNS) disorders. The company focuses on treatment for pain, including the treatment of migraines; neurological disorders, such as Parkinson’s disease; cancer treatments; and inflammatory disease. The firm acti.....



Vernalis plc
Ticker: VNLPY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 1189773133
Fax: 44 1189899300
Address: Wharfedale Road
100 Berkshire Place
Winnersh, Berkshire RG41 5RD United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Neurology & Acute Pain
Drugs-Parkinson's Disease
Drugs-Migraine
Drugs-Obesity
Drugs-Oncology
ContactsDescription
Carol FergusonDirector
Vernalis plc discovers, researches and develops new compounds for central nervous system (CNS) disorders. The company focuses on treatment for pain, including the treatment of migraines; neurological disorders, such as Parkinson’s disease; cancer treatments; and inflammatory disease. The firm acti.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Covington & Burling LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Moxatag
NameTitleSalary (GBP)Bonus (GBP)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: